Home|About This Site|About Us|Maps & Parking|Giving|Contact Us|Careers|Med-U-Nurse
Medical University Hospital home page
Center for Drug & Alcohol Programs
Search:

About the Center for Drug & Alcohol Programs

Faculty

Clinical Services
Clinical Trials
Research
Seminars
Grand Rounds
Journal Clubs
Training
Conferences
Addiction Information
Podcast Library
Video Library
Giving
Contact Us
Quick Clicks
>2005-2006 Annual Report
>2004-2005 Annual Report
>2003-2004 Annual Report
>Charleston Alcohol Research Center
>Department of Psychiatry & Behavioral Sciences
>National Institute on Alcohol Abuse and Alcoholism
>National Institute on Drug Abuse
>Research Society on Alcoholism
>Alcohol Beverage Medical Research Foundation (ABMRF)
>Clinical Neurobiology Laboratory/%CDT Testing


Patients and Visitors
Medical Services
Health Information
Community Events
Health Professionals
Home > CDAP > CDAP Clinical Trials
CDAP Clinical Trials

email icon

printer icon

print

We are currently recruiting participants for the following clinical and non-treatment studies. Each study has age and other requirements and certain clinical exclusions. One advantage of participation is that subjects receive treatment that is free of charge and confidential.  Some studies even provide payment to participants. 

Current Studies
(please select the appropriate heading to learn more about the treatment or non-treatment studies) 
ALCOHOL TREATMENT STUDIES
COCAINE TREATMENT STUDIES
NON-TREATMENT STUDIES

If you are interested in any of these studies, please call the telephone number listed for that study. 

 More information on Clinical Trials at MUSC

                        ALCOHOL TREATMENT STUDIES                      

Clinical Trial Name: Adolescent Alcohol Treatment
Funding Source: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Principal Investigator: Deborah Deas, MD, MPH
Project Coordinator: Natalie Johnson, MA
Research Assistant: Courtney Merritt, BS
Contact Person: Natalie Johnson, MA
Contact Number: 876-5070
Study Medications: Naltrexone or Placebo
Therapy: 12 weeks, after twelve week treatment phase, participants will return to the site at 6, 9, and 12 months for follow-up assessments.
Age Requirement: 15-25

Clinical Trial Name: Gabapentin as an Adjunct to Naltrexone for Alcoholism
Funding Source: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Principal Investigator: Raymond Anton, MD
Project Coordinator: Pat Latham, RN, PhD, CS
Research Assistants: Allison Hardy, BS
Contact Person: Pat Latham, RN, PhD, CS or Alicia Baros, PhD
Contact Number: 792-1230 or 792-0073
Study Medications: Naltrexone/Placebo, Naltrexone/Gabapentin, or Placebo/Placebo
Therapy: 16 weeks of individual Combine Behavioral Intervention Therapy
Age Requirement: 18-70

                          COCAINE TREATMENT STUDIES                         

Clinical Trial Name: Modafinil and CBT for Cocaine Addiction
Funding Source: National Institute on Drug Abuse (NIDA)
Principal Investigator: Robert Malcolm, MD
Research Assistant: Kelley Barnes, BA
Contact Person: Kristi Cochran Huebner, MPH or Melissa Michel, MEd
Contact Number: 792-1901
Study Medications: Modafinil or Placebo
Therapy: 8 weekly sessions of Cognitive Behavioral Therapy (CBT)
Frequency of visits: Tri-weekly visits, 1-2 week screening period, 8 week treatment period and 2 follow-up visits.
Age Requirement: 18-50

Clinical Trial Name: A Controlled Trial of N-Acetylcysteine for the Treatment of Cocaine Dependence
Funding Source: National Institute on Drug Abuse (NIDA)
Principal Investigator: Robert Malcolm, MD
Project Coordinator: Kristi Cochran Huebner, MPH or Melissa Michel, MEd
Research Assistant: Bill Lechner, BS
Contact Person: Kristi Cochran Huebner, MPH or Melissa Michel, MEd
Contact Number: 792-1901
Study Medications: N-Acetylcysteine or Placebo
Therapy: Cognitive Behavioral Therapy (CBT)
Frequency of visits: Tri-weekly visits
Age Requirement: 18-60    

NON-TREATMENT STUDIES


CDAP also recruits participants for non-treatment laboratory studies. These studies help us learn about basic biological, genetic or behavioral aspects of alcohol use and abuse. Many of these studies provide payment to participants.

Study Name: Clinical Circuitry Underlying Methamphetamine Cue Craving and Cue Extinction
Funding Source: National Institute on Drug Abuse (NIDA)
Principal Investigator: Robert Malcolm, MD
Project Coordinator: Kristi Cochran Huebner, MPH or Melissa Michel, MEd
Research Assistant: Lindsay Rogers, BA
Contact Person: Lindsay Rogers, BA
Contact Number: 792-7515
Study Medications: None
Therapy: None
Age Requirement: 18-50

Study Name: Effects on Medication Treatment on Cue-Induced Brain Activation in Alcoholics
Funding Source: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Principal Investigator: Hugh Myrick, MD
Project Coordinator: Scott Henderson, BA
Contact Person: Scott Henderson, BA
Contact Number: 792-5560
Study Medications: Aripiprazole/Gabapentin/Placebo
Therapy: None
Age Requirement: 21-65

Study Name: Evaluating the Genetic Variability of Naltrexone Response
Funding Source: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Principal Investigator: Raymond Anton, MD
Project Coordinator: Konstantin Voronin, MD, PhD
Research Assistant: Abraham Tiffany, BS
Contact Person: Abraham Tiffany, BS
Contact Number: 792-1222
Study Medications: Naltrexone/Placebo
Therapy: None
Age Requirement: 21-65

Study Name: Personality and Alcohol Preference
Funding Source: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Principal Investigator: Suzanne Thomas, PhD
Research Assistant: Brooke Manger, BA
Contact Person: Brooke Manger, BA
Contact Number: 792-5811
Study Medications: None
Therapy: None
Age Requirement: 21-65

Study Name: Stress and Subsequent Drinking in Individuals with Different Drinking Motives
Funding Source: National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Principal Investigator: Suzanne Thomas, PhD
Research Assistant: Darby Jarrett, BS
Contact Person: Darby Jarrett, BS
Contact Number: 792-4406
Study Medications: None
Therapy: None
Age Requirement: 21-40

Page last updated: 02/26/2008
privacy statements | 

disclaimer

 | accessibility |  press room |  find a doctor | site map | e-newsletters
© 2008 Medical University of South Carolina
Health on the Net Foundation sealWe subscribe to the
HONcode Principles
Verify Here